Objectives: Adiponectin is an adipocyte-derived collagen-like protein, highly specific to adipose tissue and may represent an important link between obesity and atherosclerosis. The present study was designed to investigate a possible association between serum adiponectin levels and early vascular changes in obese patients as determined by intima media thickness (IMT) and arterial pulse-wave contour analysis. Design: Obese subjects (n ¼ 47) were evaluated for arterial structure and function, metabolic parameters and serum adiponectin levels. Measurements: IMT was measured by ultrasound. Arterial elasticity was evaluated using pulse-wave contour analysis. Insulin resistance was assessed by homeostasis model assessment (HOMA-IR). Results: Adiponectin was significantly, inversely associated with mean IMT (r ¼ À0.369, P ¼ 0.011) and significantly positively associated with large artery elasticity index (LAEI) (r ¼ 0.467, P ¼ 0.001) as well as small artery elasticity index (SAEI) (r ¼ 0.462, P ¼ 0.001). In separate multivariate models, adiponectin remained significantly associated with mean IMT, LAEI and SAEI even after adjustment for cardiovascular confounders. Among metabolic parameters, adiponectin was significantly positively associated with HDL cholesterol and inversely associated with triglycerides. Adiponectin was significantly inversely associated with fasting insulin and HOMA-IR. In addition, a marginally inverse association between adiponectin and ALT was observed. Conclusions: In this study, serum adiponectin levels were significantly associated with indices of subclinical atherosclerosis, such as IMT and arterial compliance in obese patients. This association was independent of traditional cardiovascular risk factors.
Introduction
In obesity, insulin resistance is consistently observed across all age groups and may contribute to vascular atherosclerotic changes as well as excess of cardiovascular morbidity and mortality observed in these patients. [1] [2] [3] A reciprocal relationship exists between insulin resistance and endothelial dysfunction, considered to be a key initiating step in the atherosclerotic cascade. Reduced insulin action in peripheral tissue impairs endothelium-dependent vasodilatation 4 and increases the local activity of a variety of growth factors in vascular tissue, 5 promoting collagen production and the development of vascular smooth muscle cell hypertrophy. 6 Adiponectin is an adipocyte-derived collagen-like protein, highly specific to adipose tissue and may represent an important link between atherosclerosis and insulin resistance. 7 Low adiponectin levels independently predict progression of atherosclerosis 8 and increase risk of cardiovascular as well as cerebrovascular disease. 9, 10 The early vascular adverse changes in obese patients mediated by insulin resistance and low levels of adiponectin may be assessed noninvasively by intima media thickness (IMT) and arterial compliance measures. These techniques can be regarded as a valid marker of early, preclinical atherosclerosis as well as a predictor of cardiovascular morbidity and mortality. [11] [12] [13] This study was designed to investigate a possible association between serum adiponectin levels and early vascular changes in obese patients as determined by IMT and arterial pulse-wave contour analysis.
Methods
In this single-center study, 47 obese individuals (35 female patients, mean age 58.8±8.7 years) were recruited from the outpatient clinic and evaluated for the study. Obesity was defined according to World Health Organization criteria.
14 Cardiovascular risk factors were defined using the National Cholesterol Education Program risk factors categories: 15 hypertension (systolic blood pressure X140 mm Hg and/or diastolic blood pressure (BP) X90 mm Hg and/or taking antihypertensive medication); diabetes (fasting plasma glucose level X126 mg per 100 ml on at least two blood samples and/or taking glucose lowering agents, hypertriglyceridemia (X1.7 mmol l À1 ); low high-density lipoprotein cholesterol level (o1.03 mmol l À1 in men and o1.3 mmol l
À1
in women); or current cigarette smoking. Screening procedures included physical examination, complete blood chemistry, complete blood count, urinalysis and electrocardiogram. The study was approved by the local Institutional Review Board and all participants signed a full informed consent.
Biochemical parameters
Blood sampling for full chemistry and metabolic parameters, including fasting glucose, HbA1C, c-peptide, insulin, lipids profile, fibrinogen, hs-CRP, plasma adiponectin was performed. Adiponectin was determined by a commercial sandwich enzyme immunoassay technique, R&D Systems, Minneapolis, Minnesota, USA (catalog number DRP300) with 2.8% intra-assay and 6.5% inter-assay variability.
Homeostasis model assessment-insulin resistance (HOMA-IR) was calculated by the following formula: fasting plasma insulin (mU ml À1 ) Â fasting plasma glucose (mg per 100 ml)/405. 16 
Assessment of carotid atherosclerosis
The carotid IMT measurement and its reproducibility have been described in detail previously. 17 High-resolution B-mode ultrasound was used to directly image arterial walls of the extracranial carotid arteries. Subjects were examined in the supine position. The IMT was measured from nondiseased intimal and medial wall layers of the carotid artery on both sides, visualized by high-resolution 7.5 MHz ultrasound (Sonosite Titan/Sonosite, Inc., Bothell, Washington, USA). Three segments were defined: the distal 10 mm of the common carotid artery, the carotid bifurcation from the widening of the artery up to the flow divider and the proximal 10 mm of the internal carotid artery. Nine measures were obtained in each arterial segment, and the average value of all measurements was used to derive an estimate of the overall IMT in the common carotid arteries. The measurements were done during the scanning from digitized images. The mean IMT value for each was calculated by averaging values from left and right sides per subject. All ultrasonographic assessment of carotid arteries was determined by a single trained physician without the knowledge of clinical history or serum adiponectin levels.
Arterial compliance measurements
Arterial compliance evaluations were performed between 0800 and 1100 hours, in a quiet, temperature-controlled laboratory. Radial arterial waveforms were recorded for 30 s, with the subject in a supine position. The pressure transducer amplifier system was connected to a specially designed device (Model CR-2000, Hypertension Diagnostics Inc., Eagen, MN, USA). The passive transient response of the arterial vasculature to the initial loading conditions was determined by analyzing the diastolic portion of the pressure pulse-wave form. This technique, which has been validated and used extensively 18 was performed with a simple noninvasive radial pulse-wave recording and a computer analysis of the diastolic decay, providing separate assessment of the large artery or capacitive compliance (C1) and small artery reflective or oscillatory compliance (C2). Systemic vascular resistance was calculated as mean arterial pressure divided by cardiac output (CO). The mean arterial pressure is derived from waveform analysis, integrating the area under the curve and calculating the mean area of recordings during 30 s.
Statistical analysis
Analysis of data was carried out using SPSS 9.0 statistical analysis software (SPSS Inc., Chicago, IL, USA, 1999). For continuous variables, such as hemodynamic and biochemistry measures, descriptive statistics were calculated and reported as mean ± s.d.. Distributions of continuous variables were assessed for normality using the Kolmogorov-Smirnov test (cutoff at P ¼ 0.01). Associations between continuous variables with approximately normal distributions including anthropometric, hemodynamic and arterial elasticity parameters were described using Pearson's correlation coefficients. Associations between continuous variables with distributions significantly deviating from normal were described using Spearman's rho coefficients. IMT, large artery elasticity index (LAEI) and small artery elasticity index (SAEI) were each modeled using multiple linear regression analysis. All tests are two-sided and considered significant at Po0.05.
Results
Demographic and clinical characteristics of 47 obese subjects are present in Table 1 . The study participants were middle-aged (58.8±8.7 years) with body mass index 33.5 ± 7.0 kg m À2 and comprised of 35 (74.5%) female patients.
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Mean plasma levels of adiponectin were 13090.7 ± 6905.0 ng ml À1 and were normally distributed (by Kolmogorov-Smirnov test, cutoff at P ¼ 0.01). No differences in adiponectin by sex or concomitant medications were found.
As shown in Table 2 and Figure 1 , serum adiponectin concentration was significantly inversely associated with mean IMT (r ¼ À0.369, P ¼ 0.011). In multiple linear regression analysis, conventional cardiovascular risk factors such as age, sex, serum glucose, current smoking, mean arterial pressure, serum cholesterol and body mass index were included (Table 3 ). In this model adiponectin remained significantly positively associated with mean IMT even after adjustment for cardiovascular confounders.
Adiponectin was significantly positively associated with LAEI (r ¼ 0.467, P ¼ 0.001) as well as SAEI (r ¼ 0.462, P ¼ 0.001) (Table 2, Figure 1 ). In multiple linear regression analysis, conventional cardiovascular risk factors, such as age, sex, current smoking, mean arterial pressure, serum glucose, serum cholesterol and body mass index, were included (Table 3) . In these models, adiponectin remained significantly positively associated with LAEI and, separately SAEI, even after adjustment for cardiovascular confounders.
Serum adiponectin levels were not associated with systolic BP (r ¼ À0.133, P ¼ 0.373) or diastolic BP (r ¼ À0.046, P ¼ 0.758). No association between adiponectin and systemic vascular resistance was observed (r ¼ 0.028, P ¼ 0.852).
Among metabolic parameters, adiponectin was significantly, positively associated with high-density lipoprotein cholesterol (r ¼ 0.448, P ¼ 0.002), significantly inversely associated with triglycerides (r ¼ À0.362, P ¼ 0.012) and marginally inversely associated with fasting glucose (r ¼ À0.281, P ¼ 0.056). Adiponectin was significantly inversely associated with fasting insulin (r ¼ À0.457, P ¼ 0.001). As expected, adiponectin and HOMA-IR were significantly inversely associated (r ¼ À0.585, Po0.0001). In addition, a marginally inverse association between adiponectin and ALT was observed (r ¼ À0.252, P ¼ 0.087).
Among measurements of subclinical atherosclerosis themselves, a significant inverse association between mean IMT and SAEI was detected. Good correlations between arterial compliance measures (SAEI and LAEI) were also observed. LAEI was significantly inversely associated with systolic BP, HbA1C, fibrinogen and significantly positively associated with adiponectin. SAEI was marginally inversely associated with both systolic BP and HOMA-IR and significantly positively associated with adiponectin.
Discussion
In this study, serum adiponectin levels were significantly associated with indices of subclinical atherosclerosis, such as IMT and arterial compliance in obese patients. This association was independent of blood pressure level or presence of Adiponectin and vascular properties in obese patients M Shargorodsky et al cardiovascular risk factors. Findings of this study concur with previously observed correlations of adiponectin with indexes of arterial structure and function in non-diabetic postmenopausal women patients with essential hypertension and middle-aged healthy subjects. 8, 19, 20 Although adiponectin is highly specific to adipose tissue and is decreased in obesity, the impact of plasma adiponectin levels on the earliest stage of atherosclerosis in obese adults has not been investigated.
To the best of our knowledge, this study is the first to estimate a relation of serum adiponectin levels to early vascular changes identified by IMT and arterial pulse-wave contour analysis in obese adults.
Noninvasive arterial testing such as ultrasonographic measurement of carotid IMT, is considered a surrogate for systemic atherosclerotic disease burden and is predictive of cardiovascular events in asymptomatic individuals as well as recurrent events in patients with known cardiovascular disease. 21, 22 Recent technological progress has also permitted reliable measurement of vascular compliance which can be regarded as a valid marker of early atherosclerotic changes and a predictor of cardiovascular mortality. 23, 24 Moreover, small artery compliance may serve as a sensitive marker of endothelial dysfunction as well as a diagnostic vascular measurement in identifying the nitric oxide-deficient state. 25 Both tests assess different aspects of arterial structure and function and therefore combination of these tests could provide complementary information about vascular health. In this study, serum adiponectin was an independent predictor of vascular adverse changes detected by using IMT as well as arterial pulse-wave contour analysis in obese subjects. The role of adiponectin in vascular pathophysiology is not precisely known; however, low adiponectin levels promote the production of adhesion molecules in endothelial cells and proliferation of smooth muscle cells. 26 Furthermore, adiponectin knockout mice exhibit reduced endotheliumdependent vasodilatation on an atherogenic diet 27 and increased neointimal hyperplasia after acute vascular injury. 28 Consistent with these experimental findings, hypoadiponectinemia has been shown to predict the occurrence of coronary artery disease and myocardial infarction. 9 Thus, these considerations suggest an active role of adiponectin in the pathophysiology of atherosclerotic vascular disease. The link between the insulin sensitivity and early atherosclerotic changes is still under debate. A significant positive relationship between insulin resistance measured indirectly using fasting/post challenge insulin levels as well as homeostasis model assessment method and IMT has been showed in diabetic patients. 29, 30 However, such relation was not found in non-diabetic subjects. 31, 32 Moreover, no significant association between insulin sensitivity measured by the gold standard technique, such as euglycemic hyperinsulinemic clamp and IMT was observed. 33 This study did not detect an association between HOMA-IR and mean IMT, whereas a marginal association between SAEI and insulin resistance was observed. Nevertheless, serum adiponectin levels were significantly associated with IMT as well as compliance of Figure 1 Correlations between serum adiponectin levels and Large Artery Elasticity Index (a), Small Artery Elasticity Index (b), mean IMT (c) in obese subjects. Associations were described using Pearson's correlation coefficients. Adiponectin and vascular properties in obese patients M Shargorodsky et al small and large arteries. Altogether, these data suggest that adiponectin levels override insulin resistance estimated by homeostasis model assessment method as an independent marker for early vascular atherosclerotic changes in obese subjects.
In concurrence with previous studies, 20 this study did not detect an association between adiponectin and low-density lipoprotein cholesterol levels, whereas high-density lipoprotein cholesterol showed a significant correlation with adiponectin. Our study confirmed previously observed strong inverse associations between adiponectin levels and HOMA-IR. In addition, ALT identified as a marginally independent correlate of adiponectin suggesting potential links between adiponectin and liver dysfunction as well as an active role of adiponectin in the pathogenesis of nonalcoholic fatty liver disease in obese patients. 34 This study has some limitations. Our study includes a relatively small number of participants and larger studies are required to establish the role of serum adiponectin as a diagnostic marker of atherosclerosis in obese subjects as well as in the general population. In addition, as serum levels of total adiponectin were assayed in this study, the impact of different multimers of adiponectin (low, middle and high molecular weight form) on vascular pathophysiology remains unclear.
In conclusion, adiponectin emerged as an independent predictor of early atherosclerosis in obese subjects. Future research should focus on the clinical impact of low adiponectin levels and the ability of adiponectin to predict early atherosclerotic changes in the general population.
